2017 European guideline for the management of pelvic inflammatory disease
The European guideline for the management of pelvic inflammatory disease includes evidence-based advice on the investigation and treatment of pelvic inflammatory disease (PID). It has been updated to acknowledge the role of Mycoplasma genitalium as an important cause of PID with testing now recommen...
Saved in:
| Published in | International journal of STD & AIDS Vol. 29; no. 2; p. 108 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
01.02.2018
|
| Subjects | |
| Online Access | Get more information |
| ISSN | 1758-1052 |
| DOI | 10.1177/0956462417744099 |
Cover
Loading…
| Abstract | The European guideline for the management of pelvic inflammatory disease includes evidence-based advice on the investigation and treatment of pelvic inflammatory disease (PID). It has been updated to acknowledge the role of Mycoplasma genitalium as an important cause of PID with testing now recommended for women presenting with possible PID and for the male partners of women with confirmed M. genitalium infection. Recent evidence suggests that serious adverse events are uncommon when using moxifloxacin and its use is now recommended as a first-line therapy, especially in those women with M. genitalium PID. The potential utility of MRI scanning of the pelvis in excluding differential diagnoses has been highlighted. The use of doxycycline is now suggested as empirical treatment for male partners of women with PID to reduce exposure to macrolide antibiotics, which has been associated with increased resistance in M. genitalium. |
|---|---|
| AbstractList | The European guideline for the management of pelvic inflammatory disease includes evidence-based advice on the investigation and treatment of pelvic inflammatory disease (PID). It has been updated to acknowledge the role of Mycoplasma genitalium as an important cause of PID with testing now recommended for women presenting with possible PID and for the male partners of women with confirmed M. genitalium infection. Recent evidence suggests that serious adverse events are uncommon when using moxifloxacin and its use is now recommended as a first-line therapy, especially in those women with M. genitalium PID. The potential utility of MRI scanning of the pelvis in excluding differential diagnoses has been highlighted. The use of doxycycline is now suggested as empirical treatment for male partners of women with PID to reduce exposure to macrolide antibiotics, which has been associated with increased resistance in M. genitalium. |
| Author | Cusini, Marco Jensen, Jorgen Ross, Jonathan Guaschino, Secondo |
| Author_xml | – sequence: 1 givenname: Jonathan surname: Ross fullname: Ross, Jonathan organization: 1 University Hospital Birmingham NHS Foundation Trust, Birmingham, UK – sequence: 2 givenname: Secondo surname: Guaschino fullname: Guaschino, Secondo organization: 2 University of Trieste, Trieste, Italy – sequence: 3 givenname: Marco surname: Cusini fullname: Cusini, Marco organization: 3 Department of Dermatology, Fondazione IRCCS Ca' Granda Ospedale Policlinico, Milano, Italy – sequence: 4 givenname: Jorgen surname: Jensen fullname: Jensen, Jorgen organization: 4 Statens Serum Institut, Copenhagen, Denmark |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29198181$$D View this record in MEDLINE/PubMed |
| BookMark | eNo1j0tLAzEURoMo9qF7V5I_MJqbx2SylFK1UHCj65LHTY1MMsM8hP57C-rqO6vD-VbksnQFCbkD9gCg9SMzqpY1l2eWkhlzQZagVVMBU3xBVuP4xRirhTbXZMENmAYaWJIdZ6Dpdh66Hm2hxzkFbFNBGruBTp9Isy32iBnLRLtIe2y_k6epxNbmbKduONGQRrQj3pCraNsRb_92TT6et--b12r_9rLbPO0rL4SeKiVkaJTzImiGUTsJXpmg1bkyCC6M5B6UAsWYM02QAlQU3knOHXBvlOdrcv_r7WeXMRz6IWU7nA7_n_gPh9hMrQ |
| CitedBy_id | crossref_primary_10_1007_s00129_023_05086_w crossref_primary_10_1016_j_jiac_2024_07_014 crossref_primary_10_15406_ogij_2022_13_00672 crossref_primary_10_1136_sextrans_2018_053693 crossref_primary_10_1016_j_idnow_2020_12_001 crossref_primary_10_4103_enj_enj_50_21 crossref_primary_10_1016_j_gofs_2019_03_010 crossref_primary_10_1093_cid_ciy862 crossref_primary_10_1177_09564624251323678 crossref_primary_10_31631_2073_3046_2024_23_2_25_35 crossref_primary_10_1016_j_gofs_2019_03_011 crossref_primary_10_1002_ijgo_13932 crossref_primary_10_1007_s00129_024_05319_6 crossref_primary_10_7759_cureus_59760 crossref_primary_10_1016_j_med_2022_03_016 crossref_primary_10_1007_s00129_020_04716_x crossref_primary_10_1177_17557380241254025 crossref_primary_10_53126_MEBXXIII207 crossref_primary_10_30841_2708_8731_4_2023_285768 crossref_primary_10_1016_j_idnow_2022_03_001 crossref_primary_10_46563_1560_9561_2023_26_2_140_144 crossref_primary_10_1016_j_gofs_2019_03_008 crossref_primary_10_2147_IJWH_S492026 crossref_primary_10_26442_20751753_2022_7_201759 crossref_primary_10_1590_0037_8682_602_2020 crossref_primary_10_18370_2309_4117_2020_54_79_84 crossref_primary_10_3390_jcm10184145 crossref_primary_10_1093_cid_ciaa506 crossref_primary_10_1002_cbf_3671 crossref_primary_10_33667_2078_5631_2019_1_1_376__70_74 crossref_primary_10_1093_cid_ciaa101 crossref_primary_10_3390_std13030023 crossref_primary_10_1093_cid_ciaa103 crossref_primary_10_1155_2020_5423080 crossref_primary_10_1016_j_disamonth_2021_101287 crossref_primary_10_26442_20795696_2024_2_202802 crossref_primary_10_1155_2022_3650213 crossref_primary_10_1136_sextrans_2020_054468 crossref_primary_10_1097_AOG_0000000000003259 crossref_primary_10_1155_2023_3315090 crossref_primary_10_1186_s12879_019_4424_2 crossref_primary_10_33667_2078_5631_2022_24_48_53 crossref_primary_10_30841_2708_8731_7_8_2021_250830 crossref_primary_10_1186_s12905_021_01188_6 crossref_primary_10_1016_j_eimce_2021_03_008 crossref_primary_10_1016_j_jpp_2021_05_003 crossref_primary_10_1590_0037_8682_0457_2021 crossref_primary_10_3389_fcimb_2024_1351540 crossref_primary_10_1002_pds_5677 crossref_primary_10_17116_repro20182406191 crossref_primary_10_1016_j_gofs_2021_11_005 crossref_primary_10_1024_1661_8157_a003582 crossref_primary_10_3390_diagnostics13091656 crossref_primary_10_1055_a_2211_1822 crossref_primary_10_1093_cid_ciae295 crossref_primary_10_7759_cureus_38881 crossref_primary_10_1007_s40944_020_00477_6 crossref_primary_10_1016_j_eimc_2021_03_016 crossref_primary_10_53126_MEBXXVA091 crossref_primary_10_1177_1060028018817935 crossref_primary_10_1016_j_gine_2023_100892 crossref_primary_10_1016_S1283_081X_23_47977_5 crossref_primary_10_2196_45054 crossref_primary_10_1007_s00120_023_02087_4 crossref_primary_10_26416_MED_132_6_2019_2659 crossref_primary_10_1016_j_med_2024_02_025 crossref_primary_10_1007_s00129_023_05059_z crossref_primary_10_1016_j_jogoh_2021_102176 crossref_primary_10_17816_aog627260 crossref_primary_10_1016_j_mimet_2024_107030 crossref_primary_10_1016_j_sxmr_2018_12_007 crossref_primary_10_18621_eurj_1467569 crossref_primary_10_1016_j_rbmo_2023_04_008 crossref_primary_10_1016_j_jogoh_2020_101983 crossref_primary_10_2147_TCRM_S350750 crossref_primary_10_21518_2079_701X_2019_7_27_32 crossref_primary_10_1016_j_radcr_2023_07_059 crossref_primary_10_1590_s1679_4974202100011_esp1 crossref_primary_10_1186_s12905_023_02826_x crossref_primary_10_1016_S1286_9341_24_48983_7 crossref_primary_10_1177_17455057221112263 crossref_primary_10_1590_1984_3143_ar2022_0106 crossref_primary_10_7199_ped_oncall_2021_17 crossref_primary_10_18370_2309_4117_2020_51_25_31 crossref_primary_10_1177_09564624211004415 crossref_primary_10_1016_j_ejogrb_2019_05_004 crossref_primary_10_1002_ccr3_9323 crossref_primary_10_25207_1608_6228_2018_25_6_119_126 crossref_primary_10_3389_fmed_2022_888186 crossref_primary_10_1002_jum_16628 |
| ContentType | Journal Article |
| DBID | NPM |
| DOI | 10.1177/0956462417744099 |
| DatabaseName | PubMed |
| DatabaseTitle | PubMed |
| DatabaseTitleList | PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1758-1052 |
| ExternalDocumentID | 29198181 |
| Genre | Journal Article |
| GroupedDBID | --- 0R~ 18M 29J 354 35A 36B 4.4 53G 5GY 5I- 5I. 5I0 7X7 88E 88I 8AF 8AO 8C1 8FE 8FH 8FI 8FJ 8R4 8R5 AACMV AACTG AAEWN AAGLT AAGMC AAJIQ AAJOX AAJQC AAKAS AAKGS AAQXH AATBZ AAUAS AAWTL AAXOT AAXTJ AAYTG AAZBJ ABDWY ABHKI ABIVO ABJZC ABLUO ABPGX ABUJY ABUWG ABWRX ACARO ACFEJ ACFIC ACFMA ACFYK ACGBL ACGFO ACGFS ACGOD ACGZN ACGZU ACJOP ACJTF ACLFY ACLHI ACPRK ACUAV ACXMB ADBBV ADEBD ADMPF ADNBR ADTBJ ADWAY ADZCM AECGH AECVZ AEDTQ AEKYL AEMJX AENEX AEPTA AEWDL AEWLI AEXFG AFEGE AFIEG AFKRA AFKRG AFNTS AGHKR AGPXR AGWFA AHDMH AHMBA AHOKE AIEWD AIGRN AJABX AJEFB AJMMQ AJSCY AJUZI AJXAJ ALIPV ALKWR ALMA_UNASSIGNED_HOLDINGS AMCVQ AOSDY ARTOV AYAKG AZQEC BBNVY BBRGL BCR BCU BEC BENPR BHPHI BKIIM BKNYI BLC BPACV BPHCQ BVXVI BWJAD C45 CAG CCPQU COF CORYS CQQTX CS3 CUTAK DB0 DC0 DD- DE- DF0 DN0 DO- DU5 DWQXO EBS EJD EMOBN F5P FHBDP FYUFA GNUQQ H13 HCIFZ HMCUK HZ~ J8X K9- LK8 M0R M1P M2M M2P M2Q M7P MV1 NPM O9- OVD P.B P.C P2P PEA PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PSYQQ Q1R Q2X ROL S0X SAUOL SCNPE SFC SHG SJFOW SJN SPQ SPV TAE TEORI TRM UKHRP YHZ YOC |
| ID | FETCH-LOGICAL-c337t-534d85bc3d70ef7b41c59d75052d323942c1551500b98d4315f3cb422b12c95c2 |
| IngestDate | Mon Jul 21 06:00:20 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | treatment pelvic inflammatory disease Pelvic infection antibiotics guideline salpingitis |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c337t-534d85bc3d70ef7b41c59d75052d323942c1551500b98d4315f3cb422b12c95c2 |
| PMID | 29198181 |
| ParticipantIDs | pubmed_primary_29198181 |
| PublicationCentury | 2000 |
| PublicationDate | 2018-02-00 |
| PublicationDateYYYYMMDD | 2018-02-01 |
| PublicationDate_xml | – month: 02 year: 2018 text: 2018-02-00 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | International journal of STD & AIDS |
| PublicationTitleAlternate | Int J STD AIDS |
| PublicationYear | 2018 |
| SSID | ssj0006379 |
| Score | 2.4791036 |
| Snippet | The European guideline for the management of pelvic inflammatory disease includes evidence-based advice on the investigation and treatment of pelvic... |
| SourceID | pubmed |
| SourceType | Index Database |
| StartPage | 108 |
| Title | 2017 European guideline for the management of pelvic inflammatory disease |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/29198181 |
| Volume | 29 |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEF6qgngR32_ZgzeJdl_d5FisooV6sBW8SXaTiGLTgu3Fg7_dmWTzsFR8XELYpSFkvs7OfPMi5ERqYRPBjBeGFqmbuOX5zIKrwjhvJjyBMxyrkXu3ret72X1QD43GR726ZGLO7PvcupL_SBXWQK5YJfsHyZYPhQW4B_nCFSQM11_JGI5VfVry6U9TbFmFVmOROjgsc1uyxOb4FdQCpl8BCoZ5dL0en3mpktorjrDWWaI_6GRAad90Sgvyzg1dL0j4Mp1nGr5hlmZGxPbR6Y5GZbgDc-2fXaGQLZe7cerYoC7S9Gmdj2B-kcKMx0muQ8EFAe2uvihZR2s813zdXGOyrK3DHE2exZKxTaJsgZWhsZFhPkqpJtjxMJMsD1gAhgf7eXemt3axtUAWwMvAsanI9bhzvCV0UAW2z2dfBdtIu5_PuCSZaTJYI6vOp6DtHCDrpBGnG2S557ImNskN4oQWOKElTijghAJOaIUTOkpojhNaxwl1ONki91eXg4trz43Q8KwQeuIpISNfGSsi3YwTbSSzKog0Ti-MBBeB5BZtZtVsmsCPwJhUibBGcm4Yt4GyfJsspqM03iXUKKvCUPux9aVUocDH8CACpZ9EWgixR3byj_A4zvukPBafZ__bnQOyUkHokCwl8MeMj8DKm5jjTBifXa9OSQ |
| linkProvider | National Library of Medicine |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=2017+European+guideline+for+the+management+of+pelvic+inflammatory+disease&rft.jtitle=International+journal+of+STD+%26+AIDS&rft.au=Ross%2C+Jonathan&rft.au=Guaschino%2C+Secondo&rft.au=Cusini%2C+Marco&rft.au=Jensen%2C+Jorgen&rft.date=2018-02-01&rft.eissn=1758-1052&rft.volume=29&rft.issue=2&rft.spage=108&rft_id=info:doi/10.1177%2F0956462417744099&rft_id=info%3Apmid%2F29198181&rft_id=info%3Apmid%2F29198181&rft.externalDocID=29198181 |